1,3-β-D-Glucan (BDG) is a cell wall component of several fungal pathogens, including Candida and Aspergillus. Many studies have shown that evaluation of plasma BDG could be a useful test for diagnosis of invasive fungal disease (IFD) in adults with hematologic malignancies when combined with clinical, radiological and microbiological findings.
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However scanty data are available in pediatrics, and these are derived from healthy subjects or small case series of immunocompromised children with otherwise documented IFD. [4] [5] [6] [7] [8] [9] [10] We report a pediatric case of persistently high BDG levels after candidemia following megatherapy with autologous peripheral SCT (auto-PBSCT) rescue.
A 6-year-old girl diagnosed with nodular desmoplasticmedulloblastoma received antineoplastic chemotherapy and auto-PBSCT rescue at Istituto Giannina Gaslini, Genoa, Italy. During the pre-engraftment period, she received initial empirical antibacterial therapy with piperacillin-tazobactam and amikacin for febrile neutropenia. However blood cultures were positive for yeasts, subsequently identified as Candida albicans, and the patient received i.v. fluconazole (10 mg/kg/day), subsequently substituted with caspofungin 50 mg/m 2 once a day and central venous catheter removal, because of lack of clinical response and persistence of positive blood cultures. With this management, clinical conditions improved and blood cultures become negative. The patient was enrolled in a program of evaluation of the performance of BDG (evaluated by means of Fungitell assay (Associates of Cape Cod, Falmouth, MA, USA), with a positive cutoff of 60 pg/ml, according to the manufacturer's recommendations) for the diagnosis of IFD. The test was positive at very high levels (4523 pg/ml, the upper limit of detection) already 4 days before the detection of the first positive blood culture and BDG persisted highly positive (4523 pg/ml) for 3 consecutive months after blood culture negativization (Figure 1 ). During this period the patients underwent repeated diagnostic workups, both in the presence of neutropenia and after engraftment, that included abdominal ultrasound, chest computed tomogrphy scan, brain magnetic resonance imaging with contrast and fundus oculi examination, and all these tests were negative for Candida localization. Meanwhile, the patient was treated with i.v. caspofungin for a total of 4 weeks, followed by other 4 weeks of i.v. and oral voriconazole (8 mg/kg q12 h after a loading dose of 9 mg/kg q12 h) that have a good penetration in the cerebrospinal fluid. BDG plasma levels became negative approximately 3 weeks after voriconazole discontinuation.
Persistence of unexplained high BDG levels following allogeneic hemopoietic SCT has been described in adults, 11 even if at least in one patient spleen localization was detected. In our case, BDG was persistently highly positive after the 'microbiological' end of the episode and no deep organ involvement was detected in spite of extensive and repeated diagnostic workup. Many clinical factors and antibiotics have been associated with falsely positive BDG tests, 12, 13 but piperacillin-tazobactam, amikacin, fluconazole, caspofungin or voriconazole have not been observed among drugs causing false-positive BDG. Therefore, we have no clinical or microbiological explanation for our findings.
While BDG plasma level is now accepted as an useful tool for diagnosis of IFD in adults with cancer or admitted in intensive care units, 2,3,14 data in children are scarce and in some way controversial. In fact, in some small case series or single-case reports the test is reported as useful for the diagnosis of IFD, 5, 7, 14 while other studies report a lower performance, 8, 9, 14 and even falsely positive results in normal subject. 4 This case suggests that the use of BDG for the diagnosis of IFD in children pediatrics is still a very controversial topic, and further studies are needed in order to evaluate its performance both in the diagnosis and follow-up.
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